AKIN GUMP STRAUSS HAUER & FELD

Lobbying for GENENTECH INC · Biopharmaceutical company

Filing 3rd Quarter - Report

3rd Quarter (July 1 - Sep 30) 2025 · District of Columbia · House · $50,000.00 income · posted Oct 20, 2025

Lobbying activity 1

Health Issues

Issues related to public health preparedness; Issues related to access to drugs for minority communities; Issues related to healthcare education and screening.

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.